Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
British Journal of Clinical Pharmacology|November 3, 2010
A safety grading scale to support dose escalation and define stopping rules for healthy subject first-entry-into-man studies: some points to consider from the French Club Phase I working groupMichel Sibille, Alain Patat, Henri Caplain, et al.Journal of Clinical Psychopharmacology|June 23, 2011
Absence of psychostimulant effects of a supratherapeutic dose of tianeptine: a placebo-controlled study versus methylphenidate in young healthy volunteersKaty Bernard, Pierre-François Penelaud, Elisabeth Mocaër, et al.Vaccine|September 11, 2013
Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adultsStéphanie Pépin, Yves Donazzolo, Alen Jambrecina, et al.International Journal of Clinical Pharmacology and Therapeutics|April 25, 2013
Relative bioavailability of a newly developed pediatric formulation of bosentan vs. the adult formulationMarcelo M Gutierrez, Laurent B Nicolas, Yves Donazzolo, et al.European Journal of Clinical Pharmacology|June 23, 2017
A pharmacokinetic drug-drug interaction study between selexipag and midazolam, a CYP3A4 substrate, in healthy male subjectsPierre-Eric Juif, Margaux Boehler, Yves Donazzolo, et al.Journal of Cardiovascular Pharmacology|July 1, 2014
Evaluation of the effects of therapeutic and supratherapeutic doses of agomelatine on the QT/QTc interval: a phase I, randomized, double-blind, placebo-controlled and positive-controlled, crossover thorough QT/QTc study conducted in healthy volunteersYves Donazzolo, Mathilde Latreille, Marie-Anne Caillaud, et al.Human Vaccines & Immunotherapeutics|September 23, 2017
Immunogenicity and safety of the Southern Hemisphere 2015 formulation of Vaxigrip®Mathilde Latreille-Barbier, Regine Rouzier, Beatrice Astruc, et al.Gut Microbes|December 12, 2017
Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trialAlvin Ibarra, Mathilde Latreille-Barbier, Yves Donazzolo, et al.Journal of Clinical Gastroenterology|July 12, 2014
Digestive Symptoms in Healthy People and Subjects With Irritable Bowel Syndrome: Validation of Symptom Frequency QuestionnaireFernando Azpiroz, Denis Guyonnet, Yves Donazzolo, et al.European Journal of Drug Metabolism and Pharmacokinetics|November 7, 2014
CYP3A4-based drug-drug interaction: CYP3A4 substrates' pharmacokinetic properties and ketoconazole dose regimen effectXavier Boulenc, Olivier Nicolas, Stéphanie Hermabessière, et al.Pageof 4